These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 29376496)

  • 1. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
    Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
    Fallahi P; Ferrari SM; Antonelli A
    Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
    Fallahi P; Ferrari SM; Antonelli A
    Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH evaluation in hypothyroid patients assuming liquid levothyroxine at breakfast or 30 min before breakfast.
    Pirola I; Gandossi E; Brancato D; Marini F; Cristiano A; Delbarba A; Agosti B; Castellano M; Cappelli C
    J Endocrinol Invest; 2018 Nov; 41(11):1301-1306. PubMed ID: 29582344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study.
    Cappelli C; Pirola I; Daffini L; Formenti A; Iacobello C; Cristiano A; Gandossi E; Agabiti Rosei E; Castellano M
    Thyroid; 2016 Feb; 26(2):197-202. PubMed ID: 26586610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation.
    Morelli S; Reboldi G; Moretti S; Menicali E; Avenia N; Puxeddu E
    Endocrine; 2016 Jun; 52(3):571-8. PubMed ID: 26537478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.
    Fallahi P; Ferrari SM; Camastra S; Politti U; Ruffilli I; Vita R; Navarra G; Benvenga S; Antonelli A
    Obes Surg; 2017 Jan; 27(1):78-82. PubMed ID: 27272506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
    Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
    BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
    Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
    Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
    Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
    Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study.
    Fallahi P; Ragusa F; Patrizio A; Mazzi V; Botrini C; Elia G; Balestri E; Barozzi E; Rugani L; Palmisano E; Cosenza MC; Varricchi G; Ulisse S; Benvenga S; Ferrari SM; Antonelli A
    Front Endocrinol (Lausanne); 2024; 15():1386629. PubMed ID: 39027476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Altering Levothyroxine (L-T4) Doses on Quality of Life, Mood, and Cognition in L-T4 Treated Subjects.
    Samuels MH; Kolobova I; Niederhausen M; Janowsky JS; Schuff KG
    J Clin Endocrinol Metab; 2018 May; 103(5):1997-2008. PubMed ID: 29509918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.
    Ferretti E; Persani L; Jaffrain-Rea ML; Giambona S; Tamburrano G; Beck-Peccoz P
    J Clin Endocrinol Metab; 1999 Mar; 84(3):924-9. PubMed ID: 10084572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-T4 Therapy in Enteric Malabsorptive Disorders.
    Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Antonelli A
    Front Endocrinol (Lausanne); 2021; 12():626371. PubMed ID: 33708175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy and patient compliance of levothyroxine liquid and softgel formulations taken with meals: a systematic review.
    Oteri V; Volpe S; Lopes M; Sceusa G; Tumminia A; Belfiore A; Frasca F; Gullo D
    Endocrine; 2024 Aug; ():. PubMed ID: 39215906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term therapy with a new liquid L-thyroxine preparation: bioequivalence with L-T4 tablets.
    Carpi A; Toni MG; Maccheroni M; De Gaudio C
    Thyroidology; 1992 Dec; 4(3):115-9. PubMed ID: 1285037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral liquid levothyroxine treatment at breakfast: a mistake?
    Cappelli C; Pirola I; Gandossi E; Formenti A; Castellano M
    Eur J Endocrinol; 2014 Jan; 170(1):95-9. PubMed ID: 24123095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.